Literature DB >> 4139706

Ferritin, a Hodgkin's disease associated antigen.

Z Eshhar, S E Order, D H Katz.   

Abstract

Antigens which exist in high frequency in tumor tissues of patients with Hodgkin's disease have been obtained in relatively concentrated form by gel chromatography procedures. Further purification and analysis of these antigens performed in the present study have demonstrated that the antigen of fast electrophoretic mobility (F-antigen) is normal tissue ferritin. The identification of F-antigen as ferritin has been made on the basis of comparative physicochemical and immunological analyses of purified F-antigen and normal ferritin. Thus, F-antigen was found to contain iron and to be similar to ferritin in molecular weight, amino-acid composition, electrophoretic mobility, isoelectric distribution, and immunological reactivity. Absorption of a monospecific heterologous anti-F antiserum with normal tissue ferritin completely removed all anti-F antibody activity. Moreover, the absorption of polyspecific heterologous antiserum to crude Hodgkin's extracts, which contains antibodies reacting with F-antigen, the slower migrating S-antigen, and a third specificity present in lysates of normal peripheral blood lymphocytes (PL-antigen), with ferritin, removed only anti-F activity, thus distinguishing the S- and PL-antigens from ferritin. The existence of ferritin in high quantities in serum of Hodgkin's disease patients may provide a tool of potential diagnostic and prognostic importance in the management of this disease.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4139706      PMCID: PMC434305          DOI: 10.1073/pnas.71.10.3956

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  15 in total

1.  Carcino-foetal human liver ferritins.

Authors:  E Alpert; R L Coston; J W Drysdale
Journal:  Nature       Date:  1973-03-16       Impact factor: 49.962

2.  Beta-fetoprotein: identification as normal liver ferritin.

Authors:  E Alpert; K J Isselbacher; J W Drysdale
Journal:  Lancet       Date:  1973-01-06       Impact factor: 79.321

3.  Distribution of fast- and slow-migrating Hodgkin's tumor-associated antigens.

Authors:  S E Order; J Colgan; S Hellman
Journal:  Cancer Res       Date:  1974-05       Impact factor: 12.701

4.  Ferritin in body fluids.

Authors:  C W Aungst
Journal:  J Lab Clin Med       Date:  1968-03

5.  A comparison of fingerprints of tryptic digests of human, horse and rat apoferritins.

Authors:  G W Richter; G A Moppert; J C Lee
Journal:  Comp Biochem Physiol       Date:  1970-02-01

6.  The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis.

Authors:  K Weber; M Osborn
Journal:  J Biol Chem       Date:  1969-08-25       Impact factor: 5.157

7.  Isoelectric focusing in polyacrylamide gels.

Authors:  P Righetti; J W Drysdale
Journal:  Biochim Biophys Acta       Date:  1971-04-27

8.  Studies of antigens associated with Hodgkin's disease.

Authors:  S E Order; S E Chism; S Hellman
Journal:  Blood       Date:  1972-11       Impact factor: 22.113

9.  The organ-specificity of ferritin in human and horse liver and spleen.

Authors:  R R Crichton; J A Millar; R L Cumming; C F Bryce
Journal:  Biochem J       Date:  1973-01       Impact factor: 3.857

10.  SMALL-SCALE ISOLATION OF FERRITIN FOR THE ASSAY OF THE INCORPORATION OF 14C-LABELLED AMINO ACIDS.

Authors:  J W DRYSDALE; H N MUNRO
Journal:  Biochem J       Date:  1965-06       Impact factor: 3.857

View more
  21 in total

1.  Ferritin on the surface of lymphocytes in Hodgkin's disease patients. A possible blocking substance removed by levamisole.

Authors:  C Moroz; N Lahat; M Biniaminov; B Ramot
Journal:  Clin Exp Immunol       Date:  1977-07       Impact factor: 4.330

Review 2.  Immunotherapies for Hodgkin's lymphoma.

Authors:  Yvette L Kasamon; Richard F Ambinder
Journal:  Crit Rev Oncol Hematol       Date:  2007-11-19       Impact factor: 6.312

3.  Ferritin in Crohn's disease tissue: detection by electron microscopy.

Authors:  P J Whorwell; R C Baldwin; R Wright
Journal:  Gut       Date:  1976-09       Impact factor: 23.059

4.  Sensitisation to Hodgkin's disease spleen tissue in patients with malignant lymphoma: follow-up study.

Authors:  B W Hancock; L Bruce; J Richmond
Journal:  Br Med J       Date:  1976-08-07

5.  Suggested models of ecotaxopathy in lymphoreticular malignancy. A role for iron-binding proteins in the control of lymphoid cell migration.

Authors:  M de Sousa; A Smithyman; C Tan
Journal:  Am J Pathol       Date:  1978-02       Impact factor: 4.307

Review 6.  Iron and Cancer.

Authors:  Suzy V Torti; David H Manz; Bibbin T Paul; Nicole Blanchette-Farra; Frank M Torti
Journal:  Annu Rev Nutr       Date:  2018-08-21       Impact factor: 11.848

7.  Ecotaxis: the principle and its application to the study of Hodgkin's disease.

Authors:  M D Sousa; M Yang; E Lopes-Corrales; C Tan; J A Hansen; B Dupont; R A Good
Journal:  Clin Exp Immunol       Date:  1977-01       Impact factor: 4.330

8.  Poor prognostic impact of high serum ferritin levels in patients with a lower risk of diffuse large B cell lymphoma.

Authors:  Da Jung Kim; Taeyun Kim; Jee-Yeong Jeong; Jae-Cheol Jo; Won Sik Lee; Ho-Jin Shin; Ji Hyun Lee; Ho Sup Lee
Journal:  Int J Hematol       Date:  2020-01-06       Impact factor: 2.490

9.  Radioimmunotechnology for cancer diagnosis and treatment.

Authors:  S Holt; B M Longenecker; A A Noujaim
Journal:  Can Med Assoc J       Date:  1983-07-01       Impact factor: 8.262

10.  Blood iron, glutathione, and micronutrient levels and the risk of oral cancer.

Authors:  John P Richie; Wayne Kleinman; Patricia Marina; Patricia Abraham; Ernst L Wynder; Joshua E Muscat
Journal:  Nutr Cancer       Date:  2008       Impact factor: 2.900

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.